A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and ...

Patients with type 2 diabetes mellitus are at a higher risk of developing heart failure compared with the healthy population. In recent landmark clinical trials, sodium-glucose co-transporter 2 (SGLT2 ...

A new potential drug treatment for people with type 2 diabetes and obesity lowers blood sugar and increases fat burning.

Lower blood sugar and increased fat burning – without negatively affecting appetite or muscle mass. These are some of the ...

Lower blood sugar and increased fat burning—without negatively affecting appetite or muscle mass. These are some of the most ...

A new weight loss pill currently undergoing clinical trials could help burn fat and lower blood sugar levels like Ozempic and ...

A GLP-1 medication used to treat type 2 diabetes and obesity may help cut a person's monthly migraine days by about half, a ...

A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...

A recent study found that older adults with diabetes who use a GLP-1 drug have double the risk of developing wet age-related ...

Investigating tirzepatide's role in Alzheimer's reveals its potential to improve brain function and reduce inflammation, ...

The widely used class of drugs, called SGLT2 inhibitors and sold under brand names such as Jardiance and Farxiga, have been on the market for over a decade as Type 2 diabetes medications. They ...